RXO, Inc. (RXO)
NYSE: RXO · Real-Time Price · USD
28.14
+0.21 (0.75%)
At close: Nov 11, 2026, 4:00 PM EST
28.32
+0.18 (0.63%)
After-hours: Nov 11, 2026, 7:30 PM EST
RXO, Inc. Employees
RXO, Inc. had 6,906 employees as of December 31, 2025. The number of employees decreased by 634 or 8.41% compared to the previous year. That makes RXO, Inc. the 4,460th largest employer in the world and 960th in the United States.
Employees
6,906
Change (1Y)
-634
Growth (1Y)
-8.41%
Revenue / Employee
$946,858
Profits / Employee
-$12,743
Market Cap
4.64B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6,906 | -634 | -8.41% |
| Dec 31, 2024 | 7,540 | 1,489 | 24.61% |
| Dec 31, 2023 | 6,051 | -197 | -3.15% |
| Dec 31, 2022 | 6,248 | 848 | 15.70% |
| Jun 30, 2022 | 5,600 | - | - |
| Mar 31, 2022 | 5,400 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| XPO, Inc. | 38,000 |
| Knight-Swift Transportation Holdings | 37,100 |
| TFI International | 25,680 |
| Schneider National | 19,000 |
| Werner Enterprises | 14,800 |
| Saia, Inc. | 14,500 |
| ArcBest | 14,000 |
| Universal Logistics Holdings | 10,525 |
RXO News
- 11 hours ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR) - GlobeNewsWire
- 7 days ago - RXO Inc. price target raised to $30.25 from $23 at UBS - TheFly
- 9 days ago - RXO Inc. price target raised to $30 from $19 at Susquehanna - TheFly
- 12 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR) - GlobeNewsWire
- 13 days ago - RXO, Inc. Earnings release: Q3 2026 - Filings
- 13 days ago - RXO, Inc. Quarterly report: Q3 2026 - Filings
- 13 days ago - RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains - Business Wire
- 22 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG) - GlobeNewsWire